Alatrofloxacin Mesylate

甲磺酸阿曲沙星

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameAlatrofloxacin Mesylate
Drug Alias Namealatrofloxacine阿拉曲沙星阿拉曲伐沙星Alatrofloxacin mesilate阿拉沙星 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsBacterial InfectionsInfections
Global Approved IndicationsBacterial InfectionsInfections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/12/18
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer LtdPfizer Inc
Active IndicationsN/A
Inactive IndicationsBacterial InfectionsInfections

Other Information

ATC CodeJ01MA13
Related LinksWikipediaDrugBankKEGG